Table 2 Association of Reg IV expression in human glioma tissues with different clinicopathological features
From: Oncogenic reg IV is a novel prognostic marker for glioma patient survival
Clinicopathological features | No. of cases | Reg IV expression | P | |
|---|---|---|---|---|
High (n, %) | Low (n, %) | |||
WHO grade | ||||
I | 18 | 8 (44.4) | 10 (55.6) | 0.008 |
II | 14 | 8 (57.1) | 6 (42.9) | |
III | 38 | 32 (84.2) | 6 (15.8) | |
IV | 58 | 58 (100.0) | 0 (0) | |
Age | ||||
<55 | 52 | 42 (80.8) | 10 (19.2) | NS |
≥55 | 76 | 64 (84.2) | 12 (15.8) | |
Gender | ||||
Male | 76 | 64 (84.2) | 12 (15.8) | NS |
Female | 52 | 42 (80.8) | 10 (19.2) | |
KPS | ||||
<80 | 78 | 72 (92.3) | 6 (7.7) | 0.02 |
≥80 | 50 | 34 (68.0) | 16 (32.0) | |